Fontelo Paul, Bastola Mrigendra M, Zheng Zhaonian, Baik Seo Hyon
National Library of Medicine.
Res Sq. 2021 Apr 5:rs.3.rs-393440. doi: 10.21203/rs.3.rs-393440/v1.
A higher incidence of thromboembolic disorders in COVID-19 has been reported by many clinicians worldwide. Selected studies found in PubMed that reported thromboembolic events were included for meta-analysis using weighted fixed and random effects. Data from 19 articles on cohort studies in patients diagnosed with COVID-19 and thromboembolic events, including thrombosis and embolism were included in this review. The likelihood for developing thromboembolic disorders in hospitalized COVID-19 patients was 0.28 (95% CI 0.21â€"0.36). This study further validates the increased risk of VTE in COVID-19 patients when compared to healthy, non-hospitalized people, and hospitalized patients. These findings will be useful to researchers and medical practitioners caring for COVID-19 patients.
全球许多临床医生报告称，COVID-19患者中血栓栓塞性疾病的发病率较高。在PubMed上检索到的关于血栓栓塞事件的选定研究被纳入，采用加权固定效应和随机效应进行荟萃分析。本综述纳入了19篇关于COVID-19确诊患者队列研究中血栓形成和栓塞等血栓栓塞事件的数据。住院COVID-19患者发生血栓栓塞性疾病的可能性为0.28（95%CI 0.21-0.36）。与健康的非住院人群和住院患者相比，本研究进一步证实了COVID-19患者发生静脉血栓栓塞的风险增加。这些发现将对照顾COVID-19患者的研究人员和医生有用。
